New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)

Cluster of differentiation 40 (CD40) is a member of the tumour necrosis factor family and a new immune-modulating target in cancer treatment. B cells, myeloid cells and dendritic cells can express CD40 and mediate via the ligand cluster of differentiation 40 ligand (CD40L) cytotoxic T cell priming u...

Descripción completa

Detalles Bibliográficos
Autores principales: Piechutta, Manuel, Berghoff, Anna Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579575/
https://www.ncbi.nlm.nih.gov/pubmed/31275618
http://dx.doi.org/10.1136/esmoopen-2019-000510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579575/
https://www.ncbi.nlm.nih.gov/pubmed/31275618
http://dx.doi.org/10.1136/esmoopen-2019-000510

Ejemplares similares